CIK: 0002092021
申報總市值
US$3.2億
申報季度: 2026-03-31 · 持股檔數: 114
Seven Fleet Capital Management LP在最新一期 13F 報告中揭露了 114 項持股，申報期為 2026-03-31，總持股市值約為 US$3.2億，季度換手率為 147.1%。
Seven Fleet Capital Management LP 目前揭露的持股，Herfindahl 集中度指數為 0.105——換算下來相當於約 10 個等權重部位，明顯低於其實際揭露的 114 檔持股。這個落差顯示該機構的策略偏向集中在少數高信心部位，而非廣泛分散。
整體部位大小差異頗大（變異係數為 3.33），除了少數重倉部位外，還有許多規模較小的持股。
最新申報季度中，並未觀察到明顯偏向加碼既有大部位或大舉建立新部位的傾向。
目前產業板塊分類約涵蓋此投資組合揭露價值的 7%；其餘部分（例如未對應板塊的標的、選擇權或其他證券類型）尚未納入板塊分類範圍。
減碼 CGON
-95.0% -US$5778.2萬
減碼 COGT
-30.2% -US$185.4萬
減碼 SLNOEUR
-11.0% -US$214.7萬
加碼 TNGX
+133.3% US$859.6萬
加碼 AGIO
+560.2% US$622.5萬
加碼 PCVX
+327.6% US$513.2萬
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Cg Oncology INC | 股票-其他 | 30.92% | +30.92% | NEW | |
| 2 | TNGX | Tango Therapeutics INC | 股票-其他 | 3.33% | +2.04% | +133.31% | |
| 3 | RVMD | Revolution Medicines INC | 股票-醫療保健 | 2.49% | -1.06% | +22.78% | |
| 4 | TYRA | Tyra Biosciences INC | 股票-其他 | 2.38% | +0.96% | +145.96% | |
| 5 | LQDA | Liquidia CORP | 股票-其他 | 2.25% | +0.12% | +105.85% | |
| 6 | AGIO | Agios Pharmaceuticals INC | 股票-其他 | 2.25% | +1.67% | +560.24% | |
| 7 | IPSC | Century Therapeutics INC | 股票-其他 | 2.11% | +2.11% | NEW | |
| 8 | ELVN | Enliven Therapeutics INC | 股票-其他 | 2.04% | +1.00% | +64.11% | |
| 9 | PCVX | Vaxcyte INC | 股票-其他 | 2.00% | +1.21% | +327.56% | |
| 10 | ✓ | Tango Therapeutics INC | 股票-其他 | 2.00% | +2.00% | NEW | |
| 11 | COGT | Cogent Biosciences INC | 股票-其他 | 1.82% | -3.33% | -30.22% | |
| 12 | ✓ | Avalo Therapeutics INC | 股票-其他 | 1.71% | +1.71% | NEW | |
| 13 | ✓ | Minerva Neurosciences INC | 股票-其他 | 1.70% | +1.70% | NEW | |
| 14 | CGON | Cg Oncology INC | 股票-其他 | 1.63% | -40.94% | -95.00% | |
| 15 | PHVS | Pharvaris N.V. | 股票-其他 | 1.55% | +0.51% | +212.12% | |
| 16 | ABVX | Abivax Sa-adr | 股票-其他 | 1.52% | +0.29% | +218.93% | |
| 17 | DNTH | Dianthus Therapeutics INC | 股票-其他 | 1.45% | +1.04% | +270.34% | |
| 18 | ✓ | Pharvaris N V | 股票-其他 | 1.29% | +1.29% | NEW | |
| 19 | CYTK | Cytokinetics INC | 股票-醫療保健 | 1.28% | +0.84% | +492.83% | |
| 20 | SLNOEUR | Soleno Therapeutics INC | 股票-其他 | 1.23% | -2.85% | -11.00% | |
| 21 | ✓ | Enliven Therapeutics INC | 股票-其他 | 1.19% | +1.18% | NEW | |
| 22 | ERAS | Erasca INC | 股票-其他 | 1.14% | +1.14% | NEW | |
| 23 | ROIV | Roivant Sciences Ltd. | 股票-醫療保健 | 1.13% | +1.13% | NEW | |
| 24 | ✓ | Cytomx Therapeutics INC. | 股票-其他 | 1.07% | +1.06% | NEW | |
| 25 | AVTX | Avalo Therapeutics INC | 股票-其他 | 1.01% | +0.23% | +237.56% | |
| 26 | EPRX | Eupraxia Pharmaceuticals INC | 股票-其他 | 1.00% | +1.00% | NEW | |
| 27 | IDYA | Ideaya Biosciences INC | 股票-其他 | 0.91% | +0.91% | NEW | |
| 28 | TSHA | Taysha Gene Therapies INC | 股票-其他 | 0.89% | +0.27% | +274.18% | |
| 29 | ASND | Ascendis Pharma A/S | 股票-其他 | 0.88% | +0.06% | +114.80% | |
| 30 | CMPX | Compass Therapeutics INC | 股票-其他 | 0.87% | — | -9.10% | |
| 31 | DMRA | Damora Therapeutics INC | 股票-其他 | 0.83% | +0.83% | NEW | |
| 32 | 4XC1 | Kalvista Pharmaceuticals INC | 股票-其他 | 0.82% | +0.29% | +165.40% | |
| 33 | RLAY | Relay Therapeutics INC | 股票-其他 | 0.81% | +0.39% | +253.07% | |
| 34 | AXSM | Axsome Therapeutics INC | 股票-醫療保健 | 0.75% | — | +8.49% | |
| 35 | ✓ | Compass Therapeutics INC | 股票-其他 | 0.71% | +0.71% | NEW | |
| 36 | ✓ | Dianthus Therapeutics INC | 股票-其他 | 0.71% | +0.71% | NEW | |
| 37 | ✓ | Eupraxia Pharmaceuticals INC | 股票-其他 | 0.63% | +0.63% | NEW | |
| 38 | DFTX | Definium Therapeutics INC | 股票-其他 | 0.60% | +0.60% | NEW | |
| 39 | MLYS | Mineralys Therapeutics INC | 股票-其他 | 0.60% | — | +65.55% | |
| 40 | ✓ | Soleno Therapeutics INC | 股票-其他 | 0.57% | +0.57% | NEW | |
| 41 | MDGL | Madrigal Pharmaceuticals INC | 股票-醫療保健 | 0.56% | — | +82.42% | |
| 42 | CTMX | Cytomx Therapeutics INC | 股票-其他 | 0.55% | +0.41% | +659.54% | |
| 43 | LONA | Leonabio INC | 股票-其他 | 0.54% | — | +28.70% | |
| 44 | SVRA | Savara INC | 股票-其他 | 0.51% | +0.25% | +371.13% | |
| 45 | CATX | Perspective Therapeutics INC | 股票-其他 | 0.50% | +0.50% | NEW | |
| 46 | ASMB | Assembly Biosciences INC | 股票-其他 | 0.49% | — | -23.88% | |
| 47 | ✓ | Sab Biotherapeutics INC | 股票-其他 | 0.49% | +0.49% | NEW | |
| 48 | NERV | Minerva Neurosciences INC | 股票-其他 | 0.48% | +0.48% | NEW | |
| 49 | ZLAB | Zai Lab Ltd-adr | 股票-其他 | 0.46% | +0.46% | NEW | |
| 50 | TARS | Tarsus Pharmaceuticals INC | 股票-其他 | 0.44% | — | +340.00% |
Q3 2026績效
-1.3%
近4個季度績效
+8.8%
根據可用的3個月歷史資料
根據可取得價格的持股（佔申報價值的43%）計算
Seven Fleet Capital Management LP 在 2026-03-31 最顯著的持倉異動： 新建倉: Cg Oncology INC; 新建倉: Century Therapeutics INC (IPSC); 新建倉: Tango Therapeutics INC; 新建倉: Avalo Therapeutics INC; 新建倉: Minerva Neurosciences INC.
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | TNGX | Tango Therapeutics INC | +2% | +133.31% | 加碼 |
| 2 | AGIO | Agios Pharmaceuticals INC | +1.7% | +560.24% | 加碼 |
| 3 | PCVX | Vaxcyte INC | +1.2% | +327.56% | 加碼 |
| 4 | DNTH | Dianthus Therapeutics INC | +1% | +270.34% | 加碼 |
| 5 | ELVN | Enliven Therapeutics INC | +1% | +64.11% | 加碼 |
| 6 | TYRA | Tyra Biosciences INC | +1% | +145.96% | 加碼 |
| 7 | CYTK | Cytokinetics INC | +0.8% | +492.83% | 加碼 |
| 8 | PHVS | Pharvaris N.V. | +0.5% | +212.12% | 加碼 |
| 9 | CTMX | Cytomx Therapeutics INC | +0.4% | +659.54% | 加碼 |
| 10 | RLAY | Relay Therapeutics INC | +0.4% | +253.07% | 加碼 |
| 11 | ABVX | Abivax Sa-adr | +0.3% | +218.93% | 加碼 |
| 12 | 4XC1 | Kalvista Pharmaceuticals INC | +0.3% | +165.40% | 加碼 |
| 13 | TSHA | Taysha Gene Therapies INC | +0.3% | +274.18% | 加碼 |
| 14 | SVRA | Savara INC | +0.3% | +371.13% | 加碼 |
| 15 | AVTX | Avalo Therapeutics INC | +0.2% | +237.56% | 加碼 |
| 16 | LQDA | Liquidia CORP | +0.1% | +105.85% | 加碼 |
| 17 | ASND | Ascendis Pharma A/S | +0.1% | +114.80% | 加碼 |
| 18 | RVMD | Revolution Medicines INC | -1.1% | +22.78% | 加碼 |
| 19 | SLNOEUR | Soleno Therapeutics INC | -2.9% | -11.00% | 減碼 |
| 20 | COGT | Cogent Biosciences INC | -3.3% | -30.22% | 減碼 |
| 21 | CGON | Cg Oncology INC | -40.9% | -95.00% | 減碼 |
| 22 | ✓ | Cg Oncology INC | — | NEW | 新建倉 |
| 23 | IPSC | Century Therapeutics INC | — | NEW | 新建倉 |
| 24 | ✓ | Tango Therapeutics INC | — | NEW | 新建倉 |
| 25 | ✓ | Avalo Therapeutics INC | — | NEW | 新建倉 |
| 26 | ✓ | Minerva Neurosciences INC | — | NEW | 新建倉 |
| 27 | 430 | Terns Pharmaceuticals INC | — | EXIT | 清倉 |
| 28 | ✓ | Pharvaris N V | — | NEW | 新建倉 |
| 29 | ✓ | Enliven Therapeutics INC | — | NEW | 新建倉 |
| 30 | ERAS | Erasca INC | — | NEW | 新建倉 |
| 31 | ROIV | Roivant Sciences Ltd. | — | NEW | 新建倉 |
| 32 | ✓ | Cytomx Therapeutics INC. | — | NEW | 新建倉 |
| 33 | EPRX | Eupraxia Pharmaceuticals INC | — | NEW | 新建倉 |
| 34 | EXEL | Exelixis INC | — | EXIT | 清倉 |
| 35 | IDYA | Ideaya Biosciences INC | — | NEW | 新建倉 |
| 36 | DMRA | Damora Therapeutics INC | — | NEW | 新建倉 |
| 37 | ✓ | Compass Therapeutics INC | — | NEW | 新建倉 |
| 38 | ✓ | Dianthus Therapeutics INC | — | NEW | 新建倉 |
| 39 | ✓ | Eupraxia Pharmaceuticals INC | — | NEW | 新建倉 |
| 40 | DFTX | Definium Therapeutics INC | — | NEW | 新建倉 |
| 41 | ✓ | Soleno Therapeutics INC | — | NEW | 新建倉 |
| 42 | CATX | Perspective Therapeutics INC | — | NEW | 新建倉 |
| 43 | ✓ | Sab Biotherapeutics INC | — | NEW | 新建倉 |
| 44 | NERV | Minerva Neurosciences INC | — | NEW | 新建倉 |
| 45 | BLTE | Belite Bio INC - Adr | — | EXIT | 清倉 |
| 46 | ZLAB | Zai Lab Ltd-adr | — | NEW | 新建倉 |
| 47 | DYN | Dyne Therapeutics INC | — | EXIT | 清倉 |
| 48 | CRVS | Corvus Pharmaceuticals INC | — | NEW | 新建倉 |
| 49 | AM6 | Amicus Therapeutics INC | — | EXIT | 清倉 |
| 50 | ✓ | Vaxcyte INC | — | NEW | 新建倉 |
| 季度 | 申報日期 | 類型 | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-04-02 | 修正案 | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-26 | 13F-HR | 在 EDGAR 上查看 |
資產規模相近的機構
CIK 0002038170
申報總市值
US$3.2億
56 stks
2025-12-31
資料過舊，未更新
資產規模與本機構相差僅 0.0%
CIK 0001904664
申報總市值
US$3.2億
48 stks
2026-03-31
資產規模與本機構相差僅 0.0%
CIK 0002033920
申報總市值
US$3.2億
69 stks
2026-03-31
資產規模與本機構相差僅 0.0%
持倉風格相似的機構
CIK 0001595430
申報總市值
US$14.2億
17 stks
2026-03-31
前五大持倉重疊 3/5 檔，同樣重倉 Revolution Medicines INC
CIK 0001678378
申報總市值
US$4.7億
6 stks
2026-03-31
前五大持倉重疊 2/5 檔，同樣重倉 Revolution Medicines INC
CIK 0001727492
申報總市值
US$15.0億
28 stks
2026-03-31
前五大持倉重疊 2/5 檔，同樣重倉 Liquidia CORP